Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Summer S Han

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
JCO Precision Oncology|October 6, 2022
Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World OutcomesJulie Wu, Victoria Ding, Sophia Luo, et al.
Pediatrics|August 5, 2008
Macrophage migration inhibitory factor and autism spectrum disordersElena L Grigorenko, Summer S Han, Carolyn M Yrigollen, et al.
JAMA|March 9, 2021
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task ForceRafael Meza, Jihyoun Jeon, Iakovos Toumazis, et al.
JNCI Cancer Spectrum|August 26, 2024
Racial and ethnic differences in second primary lung cancer risk among lung cancer survivorsEunji Choi, Yue Hua, Chloe C Su, et al.
JAMA Oncology|December 2, 2021
Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs StudyJulie Tsu-Yu Wu, Jennifer La, Westyn Branch-Elliman, et al.
Journal of the National Cancer Institute|October 1, 2019
A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening StrategiesKevin Ten Haaf, Mehrad Bastani, Pianpian Cao, et al.
JAMA Network Open|September 26, 2023
Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non-Small Cell Lung CancerChloe C Su, Julie T Wu, Eunji Choi, et al.
JAMA Oncology|October 21, 2021
Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer ScreeningIakovos Toumazis, Koen de Nijs, Pianpian Cao, et al.
International Journal of Cancer|January 11, 2017
The impact of overdiagnosis on the selection of efficient lung cancer screening strategiesSummer S Han, Kevin Ten Haaf, William D Hazelton, et al.
Cancer Immunology, Immunotherapy : CII|December 31, 2024
Correction: The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancerJulie Tsu-Yu Wu, June Corrigan, Chloe Su, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
JCO Precision Oncology|October 6, 2022
Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World OutcomesJulie Wu, Victoria Ding, Sophia Luo, et al.
Pediatrics|August 5, 2008
Macrophage migration inhibitory factor and autism spectrum disordersElena L Grigorenko, Summer S Han, Carolyn M Yrigollen, et al.
JAMA|March 9, 2021
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task ForceRafael Meza, Jihyoun Jeon, Iakovos Toumazis, et al.
JNCI Cancer Spectrum|August 26, 2024
Racial and ethnic differences in second primary lung cancer risk among lung cancer survivorsEunji Choi, Yue Hua, Chloe C Su, et al.
JAMA Oncology|December 2, 2021
Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs StudyJulie Tsu-Yu Wu, Jennifer La, Westyn Branch-Elliman, et al.
Journal of the National Cancer Institute|October 1, 2019
A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening StrategiesKevin Ten Haaf, Mehrad Bastani, Pianpian Cao, et al.
JAMA Network Open|September 26, 2023
Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non-Small Cell Lung CancerChloe C Su, Julie T Wu, Eunji Choi, et al.
JAMA Oncology|October 21, 2021
Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer ScreeningIakovos Toumazis, Koen de Nijs, Pianpian Cao, et al.
International Journal of Cancer|January 11, 2017
The impact of overdiagnosis on the selection of efficient lung cancer screening strategiesSummer S Han, Kevin Ten Haaf, William D Hazelton, et al.
Cancer Immunology, Immunotherapy : CII|December 31, 2024
Correction: The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancerJulie Tsu-Yu Wu, June Corrigan, Chloe Su, et al.
Pageof 13